Clinical trials are a very important part of the research process. New treatments, medications and medical devices cannot be approved for use in Australia without going through clinical trials. Find out more about clinical trials.
PRAX-944 as a potential treatment for essential tremor
A clinical trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of PRAX-944 in adults with essential tremor.
The Prurigo Nodularis trial aims to assess the safety and effectiveness of a treatment to assist in reducing symptoms for people living with this condition
With REIMAGINE-4, we are comparing a potential new weight loss treatment called CagriSema to Tirzepatide (also known as Mounjaro®) in people with Type 2 Diabetes
Remibrutinib for chronic spontaneous urticaria
A clinical trial to assess a new drug for chronic spontaneous urticaria (CSU) not controlled with antihistamine medication or omalizumab (Xolair®) in the past.
Ritlecitinib in adults with non-segmental vitiligo
This trial is investigating a medication for treating people living with non-segmental vitiligo.
Sailuotong for vascular dementia or Alzheimer’s disease with cerebrovascular disease
A clinical study that is testing a new herbal medicine formula treatment for vascular dementia or Alzheimer’s disease with cerebrovascular disease.
Seladelpar as a treatment for primary biliary cholangitis (PBC)
A study to evaluate the safety and effectiveness of an investigational drug, seladelpar, in treating patients with primary biliary cholangitis (PBC).
Sodium selenate for probable behavioural variant frontotemporal dementia
A trial to test sodium selenate as a disease-modifying treatment for probable behavioural variant frontotemporal dementia (bvFTD).
Spesolimab for the treatment of generalised pustular psoriasis
A study to test whether spesolimab prevents flare-ups in patients with generalised pustular psoriasis.
Spesolimab for the treatment of hidradenitis suppurativa
A study to measure how safe and effective spesolimab (the study drug) is in treating participants with moderate to severe hidradenitis suppurativa (HS).
Study to understand risk of Alzheimer’s disease in middle-aged adults
An Australian-first online study of psychological, lifestyle and genetic factors that increase risk of Alzheimer’s disease.
Survey for carers of individuals with mental illness
A survey to better understand the experiences of caregivers and siblings of people who have experienced a manic episode or psychosis.
Swabs required for research to develop point-of-care testing for infectious diseases
ZiP Diagnostics requires human samples for research into developing point-of-care (PoC) diagnostic tests for a range of infectious diseases.
The Kite trial is investigating whether low-dose ketamine is effective in reducing depressive symptoms in adults with bipolar depression.
Tirzepatide for people with type 2 diabetes
A clinical trial investigating the safety and effectiveness of tirzepatide taken once weekly compared to insulin taken once daily in people with type 2 diabetes and increased cardiovascular risk.
Treatment for moderately to severely active ulcerative colitis
A clinical trial to assess whether guselkumab and golimumab when used together is safe and effective for treating participants with moderately to severely active ulcerative colitis (UC).
Trial to assess a new tablet for plaque psoriasis
Plaque psoriasis is an autoimmune condition characterised by dry, itchy and scaly skin patches. This trial investigates whether people with plaque psoriasis may be able to take an oral treatment to improve the condition.
Type1Screen: Diabetes autoantibody screening to identify individuals at risk for type 1 diabetes
An observational study to try and identify people at risk of developing type 1 diabetes
Understanding antigen triggers in psoriasis
A non-interventional study to investigate triggers in psoriasis.
Vagus nerve stimulation (VNS) device for the treatment of epilepsy
This post-market study involves collecting information for an already approved VNS device to get detailed information about the outcomes of people receiving the approved treatment.
WVE-003 in patients with Huntington’s disease
A multicentre, randomised, double-blind, placebo-controlled, phase 1b/2a study of WVE-003 in patients with Huntington’s disease.